| scholarly article | Q13442814 |
| P50 | author | Anne B. Newman | Q21401975 |
| Ronit Katz | Q30437553 | ||
| Stephen Seliger | Q58822334 | ||
| David S Siscovick | Q86839898 | ||
| Michael G Shlipak | Q87224063 | ||
| Mark J Sarnak | Q88732407 | ||
| Catherine Stehman-Breen | Q114401735 | ||
| P2093 | author name string | Linda F Fried | |
| P433 | issue | 20 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | circulatory system | Q11068 |
| P304 | page(s) | 2049-60 | |
| P577 | publication date | 2005-05-19 | |
| P1433 | published in | The New England Journal of Medicine | Q582728 |
| P1476 | title | Cystatin C and the risk of death and cardiovascular events among elderly persons | |
| P478 | volume | 352 |
| Q38886385 | A Modified Healthy Aging Index and Its Association with Mortality: The National Health and Nutrition Examination Survey, 1999-2002. |
| Q92747310 | A Pragmatic Cluster Randomized Trial of an Electronic Clinical Decision Support System to Improve Chronic Kidney Disease Management in Primary Care: Design, Rationale, and Implementation Experience |
| Q36108529 | A Risk Score to Guide Cystatin C Testing to Detect Occult-Reduced Estimated Glomerular Filtration Rate |
| Q21261435 | A genome-wide association for kidney function and endocrine-related traits in the NHLBI's Framingham Heart Study |
| Q89683877 | A long journey for acute kidney injury biomarkers |
| Q36520457 | APOL1 Genotype, Kidney and Cardiovascular Disease, and Death in Older Adults |
| Q37016752 | Acute Kidney Injury Biomarkers - Needs, Present Status, and Future Promise |
| Q37772785 | Acute kidney injury in elderly intensive care patients: a review |
| Q36938325 | Adiponectin and risk of coronary heart disease in older men and women |
| Q24324384 | Adiponectin regulates albuminuria and podocyte function in mice |
| Q26853272 | Advances in the use of multimarker panels for renal risk stratification |
| Q35407916 | Age and sex influence cystatin C in adolescents with and without type 1 diabetes |
| Q34455130 | Albuminuria and the risk of incident stroke and stroke types in older adults |
| Q35838825 | Albuminuria, impaired kidney function and cardiovascular outcomes or mortality in the elderly. |
| Q37783877 | Albuminuria: all you need to predict outcomes in chronic kidney disease? |
| Q51240083 | Analytical performance validation of a coronary heart disease risk assessment multi-analyte proteomic test. |
| Q41379961 | Antibiotic dosing for renal function disorders and continuous renal replacement therapy |
| Q51172231 | Antihypertensive medication use and change in kidney function in elderly adults: a marginal structural model analysis. |
| Q31071745 | Antiphospholipid Antibodies and Renal Impairment Parameters in Diabetic Nephropathy: Preliminary Data |
| Q37417971 | Apolipoprotein E and kidney function in older adults. |
| Q35137495 | Applicability of estimating glomerular filtration rate equations in pediatric patients: comparison with a measured glomerular filtration rate by iohexol clearance |
| Q46410126 | Arterial spin labeling MRI is able to detect early hemodynamic changes in diabetic nephropathy. |
| Q40169397 | Assessing the clinical utility of biomarkers in medicine |
| Q36009080 | Assessment and diagnosis of renal dysfunction in the ICU. |
| Q39118399 | Assessment of Kidney Graft Function Evolution Measured by Creatinine and Cystatin C. |
| Q30636047 | Assessment of renal function; clearance, the renal microcirculation, renal blood flow, and metabolic balance |
| Q35250898 | Association between Cystatin C and MRI Measures of Left Ventricular Structure and Function: Multi-Ethnic Study of Atherosclerosis |
| Q88615550 | Association between Obstructive Sleep Apnea and Cardiovascular Risk Factors: Variation by Age, Sex, and Race. The Multi-Ethnic Study of Atherosclerosis |
| Q36532736 | Association between chronic kidney disease detected using creatinine and cystatin C and death and cardiovascular events in elderly Mexican Americans: the Sacramento Area Latino Study on Aging |
| Q42920664 | Association between cystatin C and inflammation in patients with essential hypertension |
| Q34360040 | Association between elevated fibrosis markers and heart failure in the elderly: the cardiovascular health study |
| Q46495930 | Association between markers of renal function and C-reactive protein level in the elderly: confounding by functional status |
| Q44212877 | Association between serum cystatin C levels and coronary slow flow |
| Q40692957 | Association between serum cystatin C levels and the severity or potential risk factors of acute ischemic stroke |
| Q42649746 | Association between serum β2-microglobulin levels and frailty in an elderly Chinese population: results from RuLAS. |
| Q36246734 | Association of Body Mass Index and Body Mass Index Change with Mortality in Incident Peritoneal Dialysis Patients |
| Q91976118 | Association of Cystatin C with Metabolic Syndrome and Its Prognostic Performance in Non-ST-Segment Elevation Acute Coronary Syndrome with Preserved Renal Function |
| Q40354822 | Association of DPP-4 activity with BMD, body composition, and incident hip fracture: the Cardiovascular Health Study |
| Q28277765 | Association of FMO3 Variants and Trimethylamine N-Oxide Concentration, Disease Progression, and Mortality in CKD Patients |
| Q35993577 | Association of Kidney Disease Measures with Cause-Specific Mortality: The Korean Heart Study |
| Q34149313 | Association of Obesity and Kidney Function Decline among Non-Diabetic Adults with eGFR > 60 ml/min/1.73m(2): Results from the Multi-Ethnic Study of Atherosclerosis (MESA). |
| Q36717224 | Association of Peak Changes in Plasma Cystatin C and Creatinine With Death After Cardiac Operations |
| Q37412696 | Association of a cystatin C gene variant with cystatin C levels, CKD, and risk of incident cardiovascular disease and mortality |
| Q36652825 | Association of arterial rigidity with incident kidney disease and kidney function decline: the Health ABC study |
| Q37696905 | Association of body mass index, waist circumference, and metabolic syndrome with serum cystatin C in a Chinese population |
| Q33562005 | Association of chronic kidney disease with the spectrum of ankle brachial index the CHS (Cardiovascular Health Study). |
| Q53963735 | Association of cystatin C and depression in healthy elders: the health, aging and body composition study. |
| Q37405422 | Association of cystatin C and estimated GFR with inflammatory biomarkers: the Heart and Soul Study |
| Q33932292 | Association of cystatin C with adverse outcomes. |
| Q33637144 | Association of cystatin C with ischemia in patients with coronary heart disease |
| Q24646339 | Association of cystatin C with mortality, cardiovascular events, and incident heart failure among persons with coronary heart disease: data from the Heart and Soul Study |
| Q33276760 | Association of cystatin C with poor exercise capacity and heart rate recovery: data from the heart and soul study |
| Q41702418 | Association of epicardial adipose tissue with serum level of cystatin C in type 2 diabetes. |
| Q34660044 | Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis |
| Q36079687 | Association of fetuin-a with incident diabetes mellitus in community-living older adults: the cardiovascular health study |
| Q36667225 | Association of mild to moderate kidney dysfunction and coronary calcification |
| Q37177159 | Association of neutrophil gelatinase associated lipocalin and cystatin-C with kidney function in children with nephrotic syndrome. |
| Q37290740 | Association of renal function with cardiac calcifications in older adults: the cardiovascular health study |
| Q64898031 | Association of serum cystatin C levels with acute coronary syndrome in patients of advanced age. |
| Q47134795 | Association of serum cystatin C levels with mortality in patients with acute type A aortic dissection |
| Q95510702 | Association of urinary uromodulin with kidney function decline and mortality: the health ABC study |
| Q50995420 | Associations between biomarkers of renal function with cerebral microbleeds in hypertensive patients. |
| Q36664971 | Associations between cystatin C-based eGFR, ambulatory blood pressure parameters, and in-clinic versus ambulatory blood pressure agreement in older community-living adults |
| Q35133155 | Associations of acculturation and kidney dysfunction among Hispanics and Chinese from the Multi-Ethnic Study of Atherosclerosis (MESA) |
| Q34150807 | Associations of pentraxin-3 with cardiovascular events, incident heart failure, and mortality among persons with coronary heart disease: data from the Heart and Soul Study |
| Q50734200 | Asymmetric dimethylarginine in homocystinuria due to cystathionine beta-synthase deficiency: relevance of renal function. |
| Q46421135 | Biodemography: new approaches to understanding trends and differences in population health and mortality. |
| Q38079565 | Biomarkers in atrial fibrillation: a clinical review |
| Q38212008 | Biomarkers in cardiorenal syndromes |
| Q28087304 | Biomarkers in chronic kidney disease, from kidney function to kidney damage |
| Q26861451 | Biomarkers in nephrology: Core Curriculum 2013 |
| Q35782129 | Biomarkers of acute kidney injury |
| Q42553072 | Biomarkers of acute kidney injury |
| Q34814081 | Biomarkers of immunosuppressant organ toxicity after transplantation: status, concepts and misconceptions |
| Q33687717 | Biomarkers of nephrotoxic acute kidney injury |
| Q35917512 | Biomarkers predict progression of acute kidney injury after cardiac surgery |
| Q37323794 | Biomarkers related to aging in human populations. |
| Q38553924 | Body fluid peptide and protein signatures in diabetic kidney diseases |
| Q36426077 | CKD and sudden cardiac death: epidemiology, mechanisms, and therapeutic approaches |
| Q33561710 | CKD associates with cognitive decline |
| Q55240446 | Can Serum Cystatin C predict long-term survival in cardiac surgery patients? |
| Q80166579 | Can serial measurements of cystatin C accurately detect early renal function decline? |
| Q38218395 | Cardiorenal syndrome: acute kidney injury secondary to cardiovascular disease and role of protein-bound uraemic toxins |
| Q92145850 | Cardiovascular biomarkers predict post-discharge re-hospitalization risk and mortality among Swedish heart failure patients |
| Q37035502 | Cardiovascular risk in chronic kidney disease (CKD): the CKD-mineral bone disorder (CKD-MBD). |
| Q34631631 | Chronic kidney disease |
| Q36911521 | Chronic kidney disease (CKD) in the elderly -- a geriatrician's perspective |
| Q35176802 | Chronic kidney disease and end-stage renal disease in the elderly population: current prevalence, future projections, and clinical significance |
| Q26748992 | Chronic kidney disease and risk factors responsible for sudden cardiac death: a whiff of hope? |
| Q34663602 | Chronic kidney disease and the risk of end-stage renal disease versus death |
| Q35030634 | Chronic kidney disease in octogenarians |
| Q41298580 | Chronic kidney disease in patients with ileal conduit urinary diversion |
| Q34167837 | Chronic kidney disease is associated with white matter hyperintensity volume: the Northern Manhattan Study (NOMAS). |
| Q57119966 | Chronic kidney disease measures and the risk of abdominal aortic aneurysm |
| Q84865114 | Chronic kidney disease, 24-h blood pressure burden and their effects on silent cerebral injury and cognitive impairment: might age serve as a modulator? |
| Q82083342 | Chronic kidney disease: High eGFR and mortality: high true GFR or a marker of frailty? |
| Q37228758 | Clinical and subclinical cardiovascular disease and kidney function decline in the elderly |
| Q36925534 | Clinical associations between renal dysfunction and vascular events: A literature review |
| Q37259589 | Clinical correlates and heritability of cystatin C (from the Framingham Offspring Study) |
| Q34736194 | Clinical practice guideline for the management of chronic kidney disease in patients infected with HIV: 2014 update by the HIV Medicine Association of the Infectious Diseases Society of America |
| Q35925691 | Clinical utility of novel biomarkers in the prediction of coronary heart disease |
| Q36399815 | Cognitive Function and Kidney Disease: Baseline Data From the Systolic Blood Pressure Intervention Trial (SPRINT). |
| Q37514669 | Cognitive and kidney function: results from a British birth cohort reaching retirement age. |
| Q36638809 | Combined association of albuminuria and cystatin C-based estimated GFR with mortality, coronary heart disease, and heart failure outcomes: the Atherosclerosis Risk in Communities (ARIC) Study |
| Q36652786 | Combined association of creatinine, albuminuria, and cystatin C with all-cause mortality and cardiovascular and kidney outcomes |
| Q37680650 | Comparison of estimated GFR equations based on serum cystatin C alone and in combination with serum creatinine in patients with coronary artery disease |
| Q34267914 | Comparison of estimated glomerular filtration rate by the chronic kidney disease epidemiology collaboration (CKD-EPI) equations with and without Cystatin C for predicting clinical outcomes in elderly women |
| Q35566332 | Comparison of measured GFR, serum creatinine, cystatin C, and beta-trace protein to predict ESRD in African Americans with hypertensive CKD. |
| Q36876230 | Comparison of serum cystatin C, serum creatinine, measured GFR, and estimated GFR to assess the risk of kidney failure in American Indians with diabetic nephropathy |
| Q35819437 | Comparison of the CKD Epidemiology Collaboration (CKD-EPI) and Modification of Diet in Renal Disease (MDRD) study equations: risk factors for and complications of CKD and mortality in the Kidney Early Evaluation Program (KEEP). |
| Q37574064 | Comparisons of creatinine and cystatin C for detection of kidney disease and prediction of all-cause mortality in HIV-infected women |
| Q37056497 | Considering the inclusion of metabolic and cardiovascular markers in the Panel Study of Income Dynamics |
| Q39447438 | Contribution of cystatin C gene polymorphisms to cerebral white matter lesions |
| Q44231095 | Contribution of glomerular filtration rate to 10-year cardiovascular and mortality risk among hypertensive adults: Tehran lipid and glucose study |
| Q46106976 | Creatinine and cystatin C: what are the values? |
| Q92658895 | Creatinine versus cystatin C for renal function-based mortality prediction in an elderly cohort: The Northern Manhattan Study |
| Q92663850 | Creatinine- and cystatin C-based estimated glomerular filtration rate slopes for the prediction of kidney outcome: a comparative retrospective study |
| Q59807600 | Creatinine- versus cystatin C-based renal function assessment in the Northern Manhattan Study |
| Q34621612 | Creatinine-or cystatin C-based equations to estimate glomerular filtration in the general population: impact on the epidemiology of chronic kidney disease |
| Q37251866 | Cross-sectional study on the relationship between the level of serum cystatin C and blood pressure reverse dipping in hypertensive patients. |
| Q36682474 | Crosstalk of Various Biomarkers That Might Provide Prompt Identification of Acute or Chronic Cardiorenal Syndromes |
| Q37878418 | Current and novel renal biomarkers in heart failure |
| Q88393008 | Cystatin C Induces Insulin Resistance in Hippocampal Neurons and Promotes Cognitive Dysfunction in Rodents |
| Q35658295 | Cystatin C Is Not Causally Related to Coronary Artery Disease |
| Q37076093 | Cystatin C Predicts Incident Cardiovascular Disease in Twins |
| Q39180221 | Cystatin C and Cardiac Measures in Children and Adolescents With CKD. |
| Q30276065 | Cystatin C and Cardiovascular Disease: A Mendelian Randomization Study |
| Q39874478 | Cystatin C and NT-proBNP, a powerful combination of biomarkers for predicting cardiovascular mortality in elderly patients with heart failure: results from a 10-year study in primary care |
| Q36027716 | Cystatin C and Risk of Diabetes and the Metabolic Syndrome - Biomarker and Genotype Association Analyses |
| Q24615859 | Cystatin C and aging success |
| Q34959486 | Cystatin C and albuminuria as risk factors for development of CKD stage 3: the Multi-Ethnic Study of Atherosclerosis (MESA) |
| Q43180532 | Cystatin C and cardiac hypertrophy in primary hypertension. |
| Q46157359 | Cystatin C and cardiovascular mortality in patients with coronary artery disease and normal or mildly reduced kidney function: results from the AtheroGene study |
| Q43119836 | Cystatin C and cardiovascular risk in the general population |
| Q34614924 | Cystatin C and carotid intima-media thickness in asymptomatic adults: the Multi-Ethnic Study of Atherosclerosis (MESA). |
| Q35661812 | Cystatin C and cognitive impairment 10 years later in older women |
| Q28264774 | Cystatin C and preeclampsia: a case control study |
| Q33855997 | Cystatin C and sudden cardiac death risk in the elderly |
| Q38885905 | Cystatin C and the Risk of Frailty and Mortality in Older Men. |
| Q59796621 | Cystatin C as a Candidate Biomarker of Cardiovascular Outcomes: Too Near, but too Far from Reality |
| Q51870668 | Cystatin C as a filtration marker--haemodialysis patients expose its strengths and limitations. |
| Q36976287 | Cystatin C as a marker of cognitive function in elders: findings from the health ABC study |
| Q47264158 | Cystatin C as a predictor of cardiovascular outcomes in a hypertensive population |
| Q48433405 | Cystatin C as an index of cerebral small vessel disease: results of a cross-sectional study in community-based Japanese elderly |
| Q37181967 | Cystatin C associates with arterial stiffness in older adults |
| Q38817883 | Cystatin C attenuates insulin signaling transduction by promoting endoplasmic reticulum stress in hepatocytes |
| Q58121766 | Cystatin C for Risk Stratification in Patients After an Acute Coronary Syndrome |
| Q54531871 | Cystatin C identifies cardiovascular risk better than creatinine-based estimates of glomerular filtration in middle-aged individuals without a history of cardiovascular disease. |
| Q34457290 | Cystatin C identifies chronic kidney disease patients at higher risk for complications |
| Q36345739 | Cystatin C identifies patients with stable chronic heart failure at increased risk for adverse cardiovascular events |
| Q47563513 | Cystatin C is Indispensable for Evaluation of Kidney Disease |
| Q90108422 | Cystatin C is a useful predictor of early neurological deterioration following ischaemic stroke in elderly patients with normal renal function |
| Q51474303 | Cystatin C is associated with cardiovascular risk factors and metabolic syndrome in Aboriginal youth. |
| Q35746107 | Cystatin C is associated with inflammation but not atherosclerosis in systemic lupus erythematosus |
| Q42906280 | Cystatin C is not a better estimator of GFR than plasma creatinine in the general population |
| Q24635177 | Cystatin C level as a marker of kidney function in human immunodeficiency virus infection: the FRAM study |
| Q89347261 | Cystatin C may not be a precious predictor for coronary artery disease and its severity: an area of uncertainty |
| Q46030370 | Cystatin C provides more information than other renal function parameters for stratifying risk in patients with acute coronary syndrome. |
| Q37712784 | Cystatin C versus creatinine in determining risk based on kidney function |
| Q34772421 | Cystatin C, a marker for successful aging and glomerular filtration rate, is not influenced by inflammation. |
| Q41068700 | Cystatin C, a potential marker for cerebral microvascular compliance, is associated with white-matter hyperintensities progression. |
| Q35189962 | Cystatin C, albuminuria, and 5-year all-cause mortality in HIV-infected persons |
| Q37364907 | Cystatin C, albuminuria, and mortality among older adults with diabetes. |
| Q49041943 | Cystatin C, creatinine, estimated glomerular filtration, and long-term mortality in stroke patients |
| Q55042196 | Cystatin C, kidney function and cardiovascular disease. |
| Q31067194 | Cystatin C, left ventricular hypertrophy, and diastolic dysfunction: data from the Heart and Soul Study |
| Q35133144 | Cystatin C, mortality risk and clinical triage in US adults: threshold values and hierarchical importance |
| Q35511202 | Cystatin C, renal function, and atherosclerosis in rheumatoid arthritis |
| Q36869663 | Cystatin C--a paradigm of evidence based laboratory medicine. |
| Q41636688 | Cystatin C-Adiponectin Complex in Plasma Associates with Coronary Plaque Instability |
| Q40172117 | Cystatin C-Based Equation for Predicting the Glomerular Filtration Rate in Kidney Transplant Recipients |
| Q46324873 | Cystatin C-based estimated glomerular filtration rate and periodontitis |
| Q35071954 | Cystatin C-based renal function changes after antiretroviral initiation: a substudy of a randomized trial |
| Q37030442 | Cystatin C: A prognostic marker after myocardial infarction in patients without chronic kidney disease |
| Q27010861 | Cystatin C: a new renal marker and its potential use in small animal medicine |
| Q37856794 | Cystatin C: a step forward in assessing kidney function and cardiovascular risk |
| Q37313436 | Cystatin C: current position and future prospects |
| Q50222299 | Cystatin-C and epicardial adipose tissue as noninvasive predictors of cardiovascular risk in acromegaly |
| Q34274728 | Data mining identifies Digit Symbol Substitution Test score and serum cystatin C as dominant predictors of mortality in older men and women |
| Q34077863 | Decreased glomerular filtration rate is associated with mortality and cardiovascular events in patients with hypertension: a prospective study |
| Q39734996 | Decreased kidney function is a significant factor associated with silent cerebral infarction and periventricular hyperintensities |
| Q38162490 | Definitions of and contributions to cardiovascular disease in systemic lupus erythematosus |
| Q36971461 | Detection of chronic kidney disease with creatinine, cystatin C, and urine albumin-to-creatinine ratio and association with progression to end-stage renal disease and mortality |
| Q35901341 | Development of a Competitive Cystatin C-Specific Bioassay Suitable for Repetitive Measurements |
| Q39303610 | Diagnostic and prognostic value of galectin-3, serum creatinine, and cystatin C in chronic kidney diseases. |
| Q33849516 | Dietary protein intake and change in estimated GFR in the Cardiovascular Health Study |
| Q34604503 | Differences in kidney function and incident hypertension: the multi-ethnic study of atherosclerosis |
| Q34527591 | Differential estimation of CKD using creatinine- versus cystatin C-based estimating equations by category of body mass index |
| Q34321315 | Differential prognostic utility of NTproBNP and Cystatin C in patients with acute exacerbation of chronic pulmonary disease |
| Q43109634 | Discrepancies between creatinine- and cystatin C-based equations: implications for identification of chronic kidney disease in the general population |
| Q46573006 | Early detection of diabetic nephropathy |
| Q36326391 | Early nephropathy in type 1 diabetes: a new perspective on who will and who will not progress |
| Q37418807 | Early nephropathy in type 1 diabetes: the importance of early renal function decline |
| Q92988695 | Education and Lifestyle Factors Are Associated with DNA Methylation Clocks in Older African Americans |
| Q50600377 | Effect of Changes in Body Mass Index on Cardiovascular Outcomes in Kidney Transplant Recipients. |
| Q37593687 | Effect of blood pressure lowering on markers of kidney disease progression |
| Q45971699 | Effect of olmesartan medoxomil on cystatin C level, left ventricular hypertrophy and diastolic function. |
| Q34094835 | Effect of prolonged standardized bed rest on cystatin C and other markers of cardiovascular risk |
| Q55001439 | Effectiveness and Safety of Peritoneal Dialysis Treatment in Patients with Refractory Congestive Heart Failure due to Chronic Cardiorenal Syndrome. |
| Q84203893 | Effects of short-term addition of NSAID to diuretics and/or RAAS-inhibitors on blood pressure and renal function |
| Q43534627 | Elevated serum cystatin C in severe OSA younger men without complications |
| Q36410394 | Epidemiology and Public Health Concerns of CKD in Older Adults |
| Q37585510 | Epidemiology and prognostic significance of chronic kidney disease in the elderly--the Three-City prospective cohort study |
| Q37809748 | Epidemiology of hypertensive kidney disease |
| Q26864498 | Established and emerging markers of kidney function |
| Q36495082 | Estimated GFR and Subsequent Higher Left Ventricular Mass in Young and Middle-Aged Adults With Normal Kidney Function: The Coronary Artery Risk Development in Young Adults (CARDIA) Study |
| Q34870809 | Estimated GFR associates with cardiovascular risk factors independently of measured GFR. |
| Q34338563 | Estimated glomerular filtration rate as an independent predictor of atherosclerotic vascular disease in older women |
| Q51333288 | Estimated glomerular filtration rate from serum cystatin C: significant differences among several equations results. |
| Q91596717 | Estimated glomerular filtration rate predicts 30-day mortality in medical emergency departments: Results of a prospective multi-national observational study |
| Q51921253 | Estimated glomerular filtration rate, albuminuria and mortality in type 2 diabetes: the Casale Monferrato study. |
| Q37276263 | Estimated kidney function based on serum cystatin C and risk of subsequent coronary artery calcium in young and middle-aged adults with preserved kidney function: results from the CARDIA study |
| Q24652643 | Estimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3,418 individuals with CKD |
| Q35429171 | Estimating glomerular filtration rate from serum creatinine and cystatin C. |
| Q46836694 | Estimating glomerular filtration rate in acute coronary syndromes: Different equations, different mortality risk prediction |
| Q51940505 | Estimating glomerular filtration rate in diabetes: a comparison of cystatin-C- and creatinine-based methods. |
| Q35819414 | Estimating glomerular filtration rate in kidney transplantation: Still searching for the best marker |
| Q26860026 | Estimating glomerular filtration rate in older people |
| Q36867914 | Estimating the glomerular filtration rate from serum creatinine is better than from cystatin C for evaluating risk factors associated with chronic kidney disease |
| Q34152092 | Estimation of Glomerular Filtration Rate Based on Serum Cystatin C versus Creatinine in a Uruguayan Population. |
| Q50101203 | Evaluating estimated glomerular filtration rates of creatinine and cystatin C for male patients with chronic spinal cord injury |
| Q51906910 | Evaluation of Gentian cystatin C reagent on Abbott Ci8200 and calculation of glomerular filtration rate expressed in mL/min/1.73 m(2) from the cystatin C values in mg/L. |
| Q28084462 | Evaluation of chronic kidney disease in chronic heart failure: From biomarkers to arterial renal resistances |
| Q39135665 | Evolving biomarkers improve prediction of long-term mortality in patients with stable coronary artery disease: the BIO-VILCAD score |
| Q34627702 | Exercise electrocardiographic responses and serum cystatin C levels among metabolic syndrome patients without overt diabetes mellitus |
| Q35107128 | Exploration of chronic kidney disease prevalence estimates using new measures of kidney function in the health survey for England |
| Q37276918 | External validity of the cardiovascular health study: a comparison with the Medicare population |
| Q35907034 | Extracellular Vesicle Proteins Associated with Systemic Vascular Events Correlate with Heart Failure: An Observational Study in a Dyspnoea Cohort |
| Q97555768 | Extracellular vesicle Cystatin C and CD14 are associated with both renal dysfunction and heart failure |
| Q36020086 | Factors other than glomerular filtration rate affect serum cystatin C levels |
| Q36782677 | Fetuin-A, type 2 diabetes, and risk of cardiovascular disease in older adults: the cardiovascular health study |
| Q38998962 | Fibroblast Growth Factor 23 and the Risk of Infection-Related Hospitalization in Older Adults |
| Q33904070 | Fibroblast Growth Factor-23 and Frailty in Elderly Community-Dwelling Individuals: The Cardiovascular Health Study |
| Q35797940 | Fibroblast growth factor 23 and sudden versus non-sudden cardiac death: the Cardiovascular Health Study |
| Q37071263 | Fibroblast growth factor 23, bone mineral density, and risk of hip fracture among older adults: the cardiovascular health study |
| Q37342971 | Fibroblast growth factor 23, left ventricular mass, and left ventricular hypertrophy in community-dwelling older adults |
| Q36095111 | Fibroblast growth factor-23 and death, heart failure, and cardiovascular events in community-living individuals: CHS (Cardiovascular Health Study). |
| Q33988990 | Fibroblast growth factor-23 and early decrements in kidney function: the Heart and Soul Study |
| Q33940724 | Fibroblast growth factor-23 and incident atrial fibrillation: the Multi-Ethnic Study of Atherosclerosis (MESA) and the Cardiovascular Health Study (CHS). |
| Q37553093 | Fibroblast growth factor-23 and the long-term risk of hospital-associated AKI among community-dwelling older individuals. |
| Q35715869 | Filtration markers may have prognostic value independent of glomerular filtration rate |
| Q36862389 | First-line antihypertensive treatment in patients with pre-diabetes: rationale, design and baseline results of the ADaPT investigation. |
| Q36719260 | Fractional excretion of phosphorus modifies the association between fibroblast growth factor-23 and outcomes |
| Q37881966 | From circulating biomarkers to genomics and imaging in the prediction of cardiovascular events in the general population |
| Q28535575 | GDF-15 for prognostication of cardiovascular and cancer morbidity and mortality in men |
| Q37065589 | GFR estimating equations: getting closer to the truth? |
| Q37626254 | Glomerular filtration rate estimated using creatinine, cystatin C or both markers and the risk of clinical events in HIV-infected individuals |
| Q37901050 | Glomerular filtration rate estimation: performance of serum cystatin C-based prediction equations |
| Q33923697 | Glycosylated hemoglobin and the risk of death and cardiovascular mortality in the elderly |
| Q64124613 | Goal-Striving Stress Is Associated with Chronic Kidney Disease Among Participants in the Jackson Heart Study |
| Q47437642 | Heart Failure and Kidney Disease. |
| Q37016732 | Hematological Parameters Improve Prediction of Mortality and Secondary Adverse Events in Coronary Angiography Patients: A Longitudinal Cohort Study |
| Q29616840 | Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver |
| Q36799736 | High blood pressure accelerates gait slowing in well-functioning older adults over 18-years of follow-up. |
| Q40796648 | High cystatin C levels predict undesirable outcome for diabetic foot ulcerations |
| Q33550730 | High prevalence and diversity of kidney dysfunction in patients with type 2 diabetes mellitus and coronary artery disease: the BARI 2D baseline data |
| Q46119552 | Higher Cystatin C Levels Are Associated With Neurocognitive Impairment in Older HIV+ Adults |
| Q36635034 | Higher Levels of Cystatin C Are Associated with Extracranial Carotid Artery Steno-Occlusive Disease in Patients with Noncardioembolic Ischemic Stroke |
| Q55445827 | Higher Prevalence and Progression Rate of Chronic Kidney Disease in Elderly Patients with Type 2 Diabetes Mellitus. |
| Q91740034 | Higher albumin:creatinine ratio and lower estimated glomerular filtration rate are potential risk factors for decline of physical performance in the elderly: the Cardiovascular Health Study |
| Q35112086 | Higher biomarker-calibrated protein intake is not associated with impaired renal function in postmenopausal women. |
| Q34361219 | Higher levels of cystatin C are associated with worse cognitive function in older adults with chronic kidney disease: the chronic renal insufficiency cohort cognitive study |
| Q33568103 | Hip fractures and heart failure: findings from the Cardiovascular Health Study. |
| Q37686064 | Hospital-acquired acute kidney injury in the elderly |
| Q38987127 | Human cystatin C monomer, dimer, oligomer, and amyloid structures are related to health and disease. |
| Q38925303 | Hyperhomocysteinaemia as a potential marker of early renal function decline in middle-aged Asian people without chronic kidney disease |
| Q37868721 | Hypertension treatment update: focus on direct renin inhibition |
| Q34335929 | Identification of chromosome 3q28 and ALPK1 as susceptibility loci for chronic kidney disease in Japanese individuals by a genome-wide association study |
| Q33954425 | Identification of incident CKD stage 3 in research studies |
| Q47325664 | Impact of cystatin C levels on infarct size and hemorrhage volume in acute cerebral stroke |
| Q35694867 | Impact of the severity of obesity on microalbuminuria in obese normotensive nondiabetic individuals |
| Q33635948 | Impaired kidney function and atrial fibrillation in elderly subjects |
| Q37106389 | Impaired renal function further increases odds of 6-year coronary artery calcification progression in adults with type 1 diabetes: the CACTI study |
| Q64126098 | Improved early risk stratification with cystatin C-based estimated GFR |
| Q35020305 | Improving prognosis estimation in patients with heart failure and the cardiorenal syndrome |
| Q34069739 | Incidence of and risk factors for sick sinus syndrome in the general population |
| Q89441863 | Increased Thrombogenicity in Chronic Renal Failure in a Rat Model Induced by 5/6 Ablation/Infarction |
| Q41088013 | Increased cystatin C levels as a risk factor of cardiovascular events in patients with preserved estimated glomerular filtration rate after elective percutaneous coronary intervention with drug-eluting stents |
| Q46923821 | Increased myocardial ischemia-reperfusion injury in renal failure involves cardiac adiponectin signal deficiency |
| Q82242273 | Inflammation and dyslipidemia in nephropathy: an epidemiologic perspective |
| Q37947242 | Inflammatory markers in coronary heart disease |
| Q37386153 | Interruption of antiretroviral therapy is associated with increased plasma cystatin C |
| Q42587254 | Is Cystatin C an Important Prognostic Marker Independent of Renal Function? |
| Q93646586 | JournalScan |
| Q36495100 | Kidney Function and Cardiovascular Events in Postmenopausal Women: The Impact of Race and Ethnicity in the Women's Health Initiative |
| Q40572772 | Kidney Function and Disability-Free Survival in Older Women |
| Q36994171 | Kidney function and cognitive impairment in US adults: the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study |
| Q37245464 | Kidney function and estimated vascular risk in patients with primary dyslipidemia |
| Q46783054 | Kidney function and markers of inflammation in elderly persons without chronic kidney disease: the health, aging, and body composition study |
| Q37518114 | Kidney function and mortality in octogenarians: Cardiovascular Health Study All Stars |
| Q33804430 | Kidney function and multiple hemostatic markers: cross sectional associations in the multi-ethnic study of atherosclerosis |
| Q37248468 | Kidney function and risk of cardiovascular disease and mortality in women: a prospective cohort study |
| Q31058094 | Kidney function and systolic blood pressure new insights from cystatin C: data from the Heart and Soul Study |
| Q46952427 | Kidney function and thickness of carotid intima-media complex in patients with treated arterial hypertension |
| Q37285963 | Kidney function estimated from serum creatinine and cystatin C and peripheral arterial disease in NHANES 1999-2002. |
| Q33925821 | Kidney function of HIV-infected children in Lagos, Nigeria: using Filler's serum cystatin C-based formula |
| Q34238467 | Kidney function, albuminuria, and all-cause mortality in the REGARDS (Reasons for Geographic and Racial Differences in Stroke) study |
| Q46009914 | Kidney function, bone-mineral metabolism markers, and future risk of peripheral artery disease. |
| Q33904523 | Lack of Association between Serum Cystatin C Levels and Coronary Artery Disease in Diabetic Patients |
| Q38651014 | Lack of association between cystatin C and different coronary atherosclerotic manifestations. |
| Q36756211 | Lack of concordance in defining worsening renal function by rise in creatinine vs rise in cystatin C |
| Q37002467 | Left ventricular hypertrophy in mild and moderate reduction in kidney function determined using cardiac magnetic resonance imaging and cystatin C: the multi-ethnic study of atherosclerosis (MESA) |
| Q36206734 | Leukocyte Telomere Length in Relation to 17 Biomarkers of Cardiovascular Disease Risk: A Cross-Sectional Study of US Adults |
| Q34512274 | Limited value of cystatin-C over estimated glomerular filtration rate for heart failure risk stratification. |
| Q36411818 | Long term prognosis of acute coronary syndrome with chronic renal dysfunction treated in different therapy units at department of cardiology: a retrospective cohort study |
| Q64997778 | Long-term exposure to ambient air pollution and renal function in African Americans: the Jackson Heart Study. |
| Q37259152 | Long-term survival in adults 65 years and older with white matter hyperintensity: association with performance on the digit symbol substitution test |
| Q35744489 | Low plasma level of atrial natriuretic peptide predicts development of diabetes: the prospective Malmo Diet and Cancer study |
| Q33857515 | Markers of inflammation, coagulation, and renal function are elevated in adults with HIV infection |
| Q51544991 | Markers of renal function and acute kidney injury in acute heart failure: definitions and impact on outcomes of the cardiorenal syndrome. |
| Q38704885 | Mendelian Randomization for the Identification of Causal Pathways in Atherosclerotic Vascular Disease |
| Q50065371 | Metabolic Clusters and Outcomes in Older Adults: The Cardiovascular Health Study |
| Q34629623 | Metabolic abnormalities are present in adults with elevated serum cystatin C |
| Q34635250 | Metabolic syndrome, chronic kidney, and cardiovascular diseases: role of adipokines. |
| Q37367733 | Method of glomerular filtration rate estimation affects prediction of mortality risk |
| Q36255435 | Microalbuminuria and C-reactive protein: similar messengers of cardiovascular risk? |
| Q35893792 | Midlife Blood Pressure and Late-Life GFR and Albuminuria: An Elderly General Population Cohort |
| Q37027158 | Mild cognitive impairment: incidence and vascular risk factors in a population-based cohort |
| Q33819382 | Mild renal dysfunction and metabolites tied to low HDL cholesterol are associated with monocytosis and atherosclerosis |
| Q37588884 | Noncommunicable disease in rural India: Are we seriously underestimating the risk? The Nallampatti noncommunicable disease study |
| Q47563507 | Novel Filtration Markers for GFR Estimation |
| Q34960396 | Novel and conventional biomarkers for prediction of incident cardiovascular events in the community |
| Q38864815 | Novel biomarkers with potential for cardiovascular risk reclassification |
| Q33827728 | Novel filtration markers as predictors of all-cause and cardiovascular mortality in US adults |
| Q37432938 | Novel markers of kidney function as predictors of ESRD, cardiovascular disease, and mortality in the general population. |
| Q38252731 | Novel renal biomarkers to assess cardiorenal syndrome |
| Q38882637 | OLDER PEOPLE WITH CHRONIC KIDNEY DISEASE: DEFINITION, AND INFLUENCE OF BIOMARKERS AND MEDICATIONS UPON CARDIOVASCULAR AND RENAL OUTCOMES. |
| Q37455337 | Obesity and change in estimated GFR among older adults. |
| Q30620940 | Occult chronic kidney disease among persons with hypertension in the United States: data from the National Health and Nutrition Surveys 1988-1994 and 1999-2002. |
| Q49954920 | On the rationale of population screening for chronic kidney disease: a public health perspective |
| Q89445384 | One-year mortality of patients with ST-Elevation myocardial infarction: Prognostic impact of creatinine-based equations to estimate glomerular filtration rate |
| Q37632619 | Patterns of compensation and vulnerability in normal subjects at risk of Alzheimer's disease |
| Q37388777 | Perceived susceptibility to chronic kidney disease among high-risk patients seen in primary care practices |
| Q37883007 | Peripheral artery disease. Part 1: clinical evaluation and noninvasive diagnosis |
| Q37503824 | Pharmacologic management of the cardiorenal syndrome in heart failure |
| Q35805943 | Physical Activity Is not Associated with Estimated Glomerular Filtration Rate among Young and Middle-Aged Adults: Results from the Population-Based Longitudinal Doetinchem Study |
| Q33885961 | Physical activity and rapid decline in kidney function among older adults |
| Q97681474 | Plasma extracellular vesicle proteins are associated with stress-induced myocardial ischemia in women presenting with chest pain |
| Q33927442 | Plasma free fatty acids and risk of stroke in the Cardiovascular Health Study |
| Q48023391 | Potential contribution of adipose tissue to elevated serum cystatin C in human obesity |
| Q38669818 | Predicting acute kidney injury: current status and future challenges |
| Q37622270 | Predicting the glomerular filtration rate in bariatric surgery patients |
| Q47193628 | Predictive value of post-procedural early (within 24 h) increase in cystatin C for contrast-induced acute kidney injury and mortality following coronary angiography or intervention |
| Q36256958 | Predictive value of serum cystatin C for acute kidney injury in adults: a meta-analysis of prospective cohort trials |
| Q33591588 | Predictors of high sensitivity cardiac troponin T in chronic kidney disease patients: a cross-sectional study in the chronic renal insufficiency cohort (CRIC). |
| Q59049724 | Preinterventional Cystatin C: A Highly Prognostic Marker for All-Cause Mortality after Coronarography |
| Q84113113 | Preoperative estimated glomerular filtration rate predicts overall mortality in patients undergoing radical prostatectomy |
| Q35175419 | Presurgical serum cystatin C and risk of acute kidney injury after cardiac surgery. |
| Q88581879 | Pretransplantation Cystatin C, but not Creatinine, Predicts 30-day Cardiovascular Events and Mortality in Liver Transplant Recipients With Normal Serum Creatinine Levels |
| Q36071729 | Prevalence of CKD and comorbid illness in elderly patients in the United States: results from the Kidney Early Evaluation Program (KEEP). |
| Q37316036 | Prevalence of Reduced Kidney Function by Estimated Glomerular Filtration Rate Using an Equation Based on Creatinine and Cystatin C in Metabolic Syndrome and Its Components in Korean Adults. |
| Q90102175 | Protein Biomarkers of Cardiovascular Disease and Mortality in the Community |
| Q33710875 | Proteinuria, (99m) Tc-DTPA Scintigraphy, Creatinine-, Cystatin- and Combined-Based Equations in the Assessment of Chronic Kidney Disease. |
| Q60301801 | Proteomic analysis of heart failure hospitalization among patients with chronic kidney disease: The Heart and Soul Study |
| Q39050547 | Proteomics Research in Cardiovascular Medicine and Biomarker Discovery |
| Q38099773 | Proteomics in acute kidney injury--current status and future promise. |
| Q52680882 | Proximal Tubular Secretory Clearance: A Neglected Partner of Kidney Function. |
| Q44792456 | Putting it into perspective: multimarker panels for cardiovascular disease risk assessment |
| Q35108889 | Racial and ethnic differences in kidney function decline among persons without chronic kidney disease |
| Q35133148 | Racial differences in the association of pentraxin-3 with kidney dysfunction: the Multi-Ethnic Study of Atherosclerosis |
| Q37426809 | Racial differences in the incidence of and risk factors for atrial fibrillation in older adults: the cardiovascular health study |
| Q37477773 | Rapid decline of kidney function increases cardiovascular risk in the elderly |
| Q33887287 | Rapid kidney function decline and mortality risk in older adults |
| Q33646576 | Rate of kidney function decline in older adults: a comparison using creatinine and cystatin C. |
| Q50525796 | Red cell distribution width and risk for first hospitalization due to heart failure: a population-based cohort study. |
| Q33402590 | Reduced glomerular filtration rate and its association with clinical outcome in older patients at risk of vascular events: secondary analysis |
| Q49473827 | Reduced kidney function is associated with BMD, bone loss and markers of mineral homeostasis in older women: a 10-year longitudinal study |
| Q35805335 | Reduction in glomerular pore size is not restricted to pregnant women. Evidence for a new syndrome: 'Shrunken pore syndrome'. |
| Q35652795 | Reductions in Plasma Cystatin C After Initiation of Antiretroviral Therapy Are Associated With Reductions in Inflammation: ACTG A5224s |
| Q34978336 | Relationship between Systemic and Cerebral Vascular Disease and Brain Structure Integrity in Normal Elderly Individuals |
| Q33905277 | Relationship between cystatin C and coronary artery atherosclerosis progression differs by type 1 diabetes |
| Q37615466 | Relationship between serum cystatin C and polycystic ovary syndrome |
| Q82732442 | Relationship between serum cystatin C and serum adiponectin level in type 2 diabetic patients |
| Q64080402 | Relationship of High Circulating Cystatin C to Biochemical Markers of Bone Turnover and Bone Mineral Density in Elderly Males with a Chronic Heart Failure |
| Q33721299 | Relative risks of chronic kidney disease for mortality and end-stage renal disease across races are similar |
| Q90148126 | Relative value of cystatin C and creatinine-based estimates of glomerular filtration rate in predicting long-term mortality after cardiac surgery: a cohort study |
| Q46140530 | Reliability of equations to estimate glomerular filtration rate in the very old. |
| Q37089078 | Renal dysfunction in burns: a review |
| Q57956749 | Renal function and cardiovascular events: relevance of eGFR and albuminuria in patients with diabetes |
| Q40105964 | Renal function and rate of hip bone loss in older men: the Osteoporotic Fractures in Men Study. |
| Q34254221 | Renal function is a determinant of subjective well-being in active seniors but not in patients with subjective memory complaints |
| Q33818135 | Renal function is related to severity of coronary artery calcification in elderly persons: the Rotterdam study |
| Q37238605 | Renal function predicts survival in patients with acute ischemic stroke |
| Q34221460 | Renal protection in diabetes: lessons from ONTARGET® |
| Q26748488 | Renalase and Biomarkers of Contrast-Induced Acute Kidney Injury |
| Q42736998 | Response: Lack of Association between Serum Cystatin C Levels and Coronary Artery Disease in Diabetic Patients (Korean Diabetes J 2010;34:95-100). |
| Q42842267 | Response: The Association of Serum Cystatin C with Glycosylated Hemoglobin in Korean Adults (Diabetes Metab J 2016;40:62-9). |
| Q42941017 | Risk factors for ESRD: lessons from a community study and implications for public health |
| Q34623834 | Risk factors for cardiovascular disease across the spectrum of older age: the Cardiovascular Health Study. |
| Q36438147 | Risk factors for coronary artery calcium among patients with chronic kidney disease (from the Chronic Renal Insufficiency Cohort Study). |
| Q58121740 | Role for Cystatin C-Based Risk Stratification for Patients After Acute Coronary Syndrome in the Era of High Sensitivity Cardiac Troponin Assays |
| Q33639802 | Screening for chronic kidney disease in HIV-infected patients |
| Q37835610 | Screening tests for renal impairment in patients with type 2 diabetes: the what, when, and how. |
| Q34629749 | Self-rated health and adverse events in CKD. |
| Q35983519 | Serum 25-hydroxyvitamin D and change in estimated glomerular filtration rate |
| Q57162227 | Serum Calcitriol Concentrations and Kidney Function Decline, Heart Failure, and Mortality in Elderly Community-Living Adults: The Health, Aging, and Body Composition Study |
| Q91629328 | Serum Cystatin C and Arterial Stiffness in Middle-Aged and Elderly Adults without Chronic Kidney Disease: A Population-Based Study |
| Q40998882 | Serum Cystatin C and the Risk of Coronary Heart Disease in Ethnic Chinese Patients With Normal Renal Function |
| Q36241451 | Serum Cystatin C, Markers of Chronic Kidney Disease, and Retinopathy in Persons with Diabetes |
| Q36334563 | Serum concentration of cystatin C and risk of end-stage renal disease in diabetes |
| Q37126608 | Serum creatinine and functional limitation in elderly persons |
| Q36829863 | Serum creatinine level, a surrogate of muscle mass, predicts mortality in critically ill patients |
| Q43877569 | Serum cystatin C and emphysema: results from the National Health and Nutrition Examination Survey (NHANES). |
| Q33904510 | Serum cystatin C as a biomarker for predicting coronary artery disease in diabetes |
| Q83327450 | Serum cystatin C as a predictor for cardiovascular events in end-stage renal disease patients at the initiation of dialysis |
| Q37229937 | Serum cystatin C concentration as an independent marker for hypertensive left ventricular hypertrophy |
| Q34940161 | Serum cystatin C is a determinant of central pressure augmentation index measured by oscillometric method in renal transplant recipients |
| Q53704024 | Serum cystatin C is an independent biomarker associated with the renal resistive index in patients with chronic kidney disease. |
| Q47638003 | Serum cystatin C is associated with kidney function but not with cardiovascular risk factors or subclinical atherosclerosis in patients with Systemic Lupus Erythematosus |
| Q47579396 | Serum cystatin C is associated with subclinical atherosclerosis in patients with type 2 diabetes: A retrospective study |
| Q92340460 | Serum cystatin C levels relate to no-reflow phenomenon in percutaneous coronary interventions in ST-segment elevation myocardial infarction |
| Q34664889 | Serum cystatin C levels to predict serum concentration of digoxin in Japanese patients. |
| Q35661440 | Serum cystatin C reflects the progress of albuminuria |
| Q36392738 | Serum cystatin C- versus creatinine-based definitions of acute kidney injury following cardiac surgery: a prospective cohort study |
| Q37141019 | Serum extracellular vesicle protein levels are associated with acute coronary syndrome |
| Q37280851 | Short-term changes after a weight reduction intervention in advanced diabetic nephropathy |
| Q36482364 | Shrunken Pore Syndrome is associated with a sharp rise in mortality in patients undergoing elective coronary artery bypass grafting |
| Q37217566 | Significance of Cystatin C for Early Diagnosis of Contrast-Induced Nephropathy in Patients Undergoing Coronary Angiography |
| Q36328272 | Soluble endothelial cell selective adhesion molecule and cardiovascular outcomes in patients with stable coronary disease: A report from the Heart and Soul Study |
| Q42839516 | Special considerations in the management of chronic kidney disease in the elderly |
| Q38373457 | Subclinical Atherosclerosis, Cardiac and Kidney Function, Heart Failure, and Dementia in the Very Elderly |
| Q51628025 | Subclinical Organ Damage in White-Coat Hypertension: The Possible Role of Cystatin C. |
| Q34251962 | Subclinical vascular disease burden and longer survival |
| Q47649980 | Subjective Age and Cystatin C Among Older Adults. |
| Q35165510 | Systematic shifts in cystatin C between 2006 and 2010. |
| Q36621001 | The Association of Serum Cystatin C with Glycosylated Hemoglobin in Korean Adults. |
| Q53723838 | The Diabetic Foot as a Proxy for Cardiovascular Events and Mortality Review. |
| Q36492773 | The association between elevated cystatin C levels with myocardial infarction: a meta-analysis |
| Q33763020 | The association between renal function biomarkers and subclinical cardiovascular measures in African Caribbean families |
| Q35160307 | The association of chronic kidney disease and metabolic syndrome with incident cardiovascular events: multiethnic study of atherosclerosis |
| Q35557044 | The effect of including cystatin C or creatinine in a cardiovascular risk model for asymptomatic individuals: the multi-ethnic study of atherosclerosis |
| Q34258691 | The effects of cystatin C and alkaline phosphatase changes on cognitive function 12-months after bariatric surgery |
| Q37329902 | The epidemic challenge of chronic kidney disease in older patients |
| Q34210655 | The impact of demographic characteristics and lifestyle in the distribution of cystatin C values in a healthy greek adult population |
| Q37464722 | The link between obesity and albuminuria: adiponectin and podocyte dysfunction |
| Q44983748 | The potential of Cystatin C and small dense LDL as biomarkers of coronary artery disease risk in a young Indian population |
| Q37078158 | The prevalence of chronic kidney disease (CKD) and the associated factors to CKD in urban Korea: a population-based cross-sectional epidemiologic study |
| Q42340184 | The prognostic importance of cystatin C in severe systolic dysfunction without chronic kidney disease |
| Q39138386 | The public health dimension of chronic kidney disease: what we have learnt over the past decade |
| Q48497793 | The relationship between intracranial arterial stenosis and glomerular filtration rate |
| Q55251630 | The relationship between kidney function and quality of life among community-dwelling adults varies by age and filtration marker. |
| Q42772483 | The relationship of cystatin C, creatinine, estimated GFR, and cardiovascular events |
| Q35785324 | The risk of infection-related hospitalization with decreased kidney function |
| Q48851857 | The role of cystatin C in vascular remodeling of balloon-injured abdominal aorta of rabbits |
| Q82387661 | The role of high-sensitivity C-reactive Protein, interleukin-6 and cystatin C in ischemic stroke complicating atrial fibrillation |
| Q35013304 | The roles of the skeleton and phosphorus in the CKD mineral bone disorder |
| Q48516102 | The shrunken pore syndrome is associated with declined right ventricular systolic function in a heart failure population - the HARVEST study. |
| Q57391974 | Trajectories of function and biomarkers with age: the CHS All Stars Study |
| Q37022037 | Trajectories of kidney function decline in young black and white adults with preserved GFR: results from the Coronary Artery Risk Development in Young Adults (CARDIA) study |
| Q35203365 | Trefoil factor 3 predicts incident chronic kidney disease: a case-control study nested within the Atherosclerosis Risk in Communities (ARIC) study |
| Q33859246 | Trends in the prevalence of chronic kidney disease, other chronic diseases and health-related behaviors in an adult Korean population: data from the Korean National Health and Nutrition Examination Survey (KNHANES). |
| Q37126287 | Update on cystatin C: incorporation into clinical practice |
| Q44901632 | Uric acid measurement improves prediction of cardiovascular mortality in later life. |
| Q34639560 | Urinary Cystatin C as a Potential Risk Marker for Cardiovascular Disease and Chronic Kidney Disease in Patients with Obesity and Metabolic Syndrome |
| Q39060028 | Urinary Uromodulin and Risk of Urinary Tract Infections: The Cardiovascular Health Study |
| Q30450879 | Urinary biomarkers as a diagnostic tool for acute kidney injury |
| Q36299917 | Urinary uromodulin, kidney function, and cardiovascular disease in elderly adults |
| Q36104818 | Urine Collagen Fragments and CKD Progression-The Cardiovascular Health Study |
| Q37041666 | Use of Framingham risk score and new biomarkers to predict cardiovascular mortality in older people: population based observational cohort study. |
| Q33778097 | Use of cystatin C to inform metformin eligibility among adult veterans with diabetes |
| Q51031011 | Utility of cystatin C-derived equations for evaluation of residual renal function in peritoneal dialysis patients. |
| Q46085999 | Validation of a new plasma cystatin C-based formula and the Modification of Diet in Renal Disease creatinine-based formula for determination of glomerular filtration rate. |
| Q83674469 | Variability in CKD stage in outpatients followed in two large renal clinics |
| Q37622100 | Vascular risk factors and cognitive decline in a population sample |
| Q35534744 | Vitamin D, parathyroid hormone, and cardiovascular events among older adults |
| Q46001968 | [How to carry out the search of kidney disease in patients with cardiovascular disease?]. |
| Q42561003 | β-trace protein versus cystatin C: which is a better surrogate marker of renal function versus prognostic indicator in cardiovascular diseases? |
| Q35026210 | β2-microglobulin, cystatin C, and creatinine and risk of symptomatic peripheral artery disease |
Search more.